Nasdaq Mbii News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq mbii. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Mbii Today - Breaking & Trending Today

Marrone Bio Innovations, Inc. (NASDAQ:MBII) Short Interest Up 31.1% in April

Marrone Bio Innovations, Inc. (NASDAQ:MBII – Get Rating) was the target of a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 2,360,000 shares, an increase of 31.1% from the April 15th total of 1,800,000 shares. Approximately 2.5% of the shares of the stock are […] ....

Pamelag Marrone , Vident Investment Advisory , Marrone Bio Innovations Inc , Charles Schwab Investment Management Inc , Zacks Investment Research , Canaccord Genuity Group , Marrone Bio Innovations , Get Rating , Genuity Group , Director Pamela , Street Corp , Investment Advisory , Schwab Investment Management , Bio Innovations , Nasdaq Mbii , Basic Material ,

Marrone Bio Innovations (NASDAQ:MBII) Issues Earnings Results, Misses Expectations By $0.02 EPS

Marrone Bio Innovations (NASDAQ:MBII – Get Rating) released its earnings results on Wednesday. The basic materials company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02), MarketWatch Earnings reports. Marrone Bio Innovations had a negative return on equity of 65.95% and a negative net margin of 47.07%. During […] ....

United States , Pamelag Marrone , Securities Exchange Commission , Marrone Bio Innovations Inc , Goldman Sachs Group Inc , Marrone Bio Innovations Company Profile Get Rating , Virtu Financial , Zacks Investment Research , America Corp , Wells Fargo Company , Canaccord Genuity Group , Citadel Advisors , Marrone Bio Innovations , Get Rating , Marketwatch Earnings , Bio Innovations , Director Pamela , Exchange Commission , Sachs Group , Investment Research , Genuity Group , Bio Innovations Company Profile , Nasdaq Mbii , Basic Material ,

Analysts Set Marrone Bio Innovations, Inc. (NASDAQ:MBII) Price Target at $2.08

Marrone Bio Innovations, Inc. (NASDAQ:MBII – Get Rating) has earned a consensus recommendation of “Buy” from the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month target […] ....

United States , Thomson Reuter , Pamelag Marrone , Clear Harbor Asset Management , Marrone Bio Innovations Inc , Zacks Investment Research , Parametric Portfolio Associates , Sg Americas Securities , Wells Fargo Company , Philadelphia Trust Co , Canaccord Genuity Group , Marrone Bio Innovations , Get Rating , Marketbeat Ratings , Genuity Group , Investment Research , Director Pamela , Portfolio Associates , Harbor Asset Management , Bio Innovations , Nasdaq Mbii , Basic Material ,

Marrone Bio Innovations (NASDAQ:MBII) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Marrone Bio Innovations (NASDAQ:MBII – Get Rating) in a report issued on Saturday. The firm set a “sell” rating on the basic materials company’s stock. Other equities analysts also recently issued research reports about the company. Canaccord Genuity Group downgraded Marrone Bio Innovations from a “buy” rating to a […] ....

Zelto Nematicide , Majestene Nematicide , Zequanox Molluscicide , Morgan Stanley , Northern Trust Corp , Marrone Bio Innovations Inc , Regalia Rx Plant Health , Zacks Investment Research , Nuveen Asset Management , Renaissance Technologies , Canaccord Genuity Group , Marrone Bio Innovations , Get Rating , Genuity Group , Investment Research , Bio Innovations , Trust Corp , Asset Management , State Street Corp , Street Corp , Grandevo Insecticide , Regalia Fungicide , Stargus Fungicide , Venerate Insecticide , Amplitude Fungicide , Nasdaq Mbii ,